# FDA 483 - AGC Biologics, Inc. - March 27, 2024

Source: https://www.globalkeysolutions.net/records/483/agc-biologics-inc/80841175-6756-4121-a1db-5a18be9e04f7

> FDA 483 for AGC Biologics, Inc. on March 27, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: AGC Biologics, Inc.
- Inspection Date: 2024-03-27
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2021-07-12](https://www.globalkeysolutions.net/records/483/agc-biologics-inc/a64fbf9d-4ce0-40d6-85ff-5280ce487ffc)
- [483 - 2023-02-10](https://www.globalkeysolutions.net/records/483/agc-biologics-inc/642c5042-ad56-4c71-91da-5d256a20fc36)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/agc-biologics-inc/49ec8f79-84b2-46f1-a91e-0d626ba4bf60)
- [483 - 2024-03-27](https://www.globalkeysolutions.net/records/483/agc-biologics-inc/1ae2bd69-95b9-4aa9-8673-4ed83ff4a444)
- [EIR - 2021-03-19](https://www.globalkeysolutions.net/records/eir/agc-biologics-inc/7a3e7ea1-7f89-4fff-9f88-dade096c5e9f)

## Related Officers

- [Jiangping Jiang](https://www.globalkeysolutions.net/people/jiangping-jiang/02f0ccbd-77f2-4bf6-b652-1b0fef2f2a05)
- [Ian L. McWilliams](https://www.globalkeysolutions.net/people/ian-l-mcwilliams/386bf0ca-a66d-4526-9b07-7771795269a1)
- [other](https://www.globalkeysolutions.net/people/jeanne-m-fringer/4d970694-416e-42d6-9ec3-7bf3e337fb9a)
- [Mercy Oyugi](https://www.globalkeysolutions.net/people/mercy-oyugi/9da8ebdc-a4c6-4666-9096-9a17f4edcf6c)
- [Investigator](https://www.globalkeysolutions.net/people/michael-r-shanks/dd24952b-4309-451e-afe8-f68892cd7bac)

Company: https://www.globalkeysolutions.net/companies/agc-biologics-inc/9759f733-dd5f-4f2e-a516-f1b37fad39e2

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd